Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: A retrospective study of 300 patients-Reference-Cited by-同舟云学术

Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: A retrospective study of 300 patients

Published:2012-10 Issue:1 Volume:78 Page:112-120
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Nagy-Mignotte Hélène,Guillem Pascale,Vignoud Lucile,Coudurier Marie,Vesin Aurélien,Bonneterre Vincent,Toffart Anne-Claire,Sakhri Linda,Brambilla Christian,Brambilla Elisabeth,Timsit Jean-François,Moro-Sibilot Denis

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. Current status of second-line treatment and novel therapies for small cell lung cancer;Tiseo;J Thorac Oncol,2007

2. Lung cancer: recent advances;Lee;Ann Acad Med Singapore,2010

3. Trends in the outcomes for patients with limited stage small cell lung cancer: an analysis of the Surveillance, Epidemiology, and End Results database;Lally;Lung Cancer,2009

4. Could we expect to improve survival in small cell lung cancer?;El Maalouf;Lung Cancer,2007

5. Small cell lung cancer: state of the art and future perspectives;Stupp;Lung Cancer,2004

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with extensive disease small cell lung cancer;Respiratory Medicine and Research;2024-11

2. Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancer;J CANCER RES THER;2023

3. The Impact of Chemosensitivity on the Outcome of Brain Metastases in Small-Cell Lung Cancer: A Retrospective Analysis;Current Oncology;2022-10-21

4. The prognostic effect of chemosensitivity on brain metastases in small-cell lung cancer: A retrospective analysis;2022-08-23

5. Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer;Investigational New Drugs;2022-06-24